It is estimated that the market size of the domestic stem cell industry will reach 100 billion yuan by 2016.
Medical Network, August 26-the State Health and Family Planning Commission and the State Food and Drug Administration recently jointly issued China's first "measures for the Administration of Stem Cell Clinical Research", which standardizes the institutional qualifications and conditions of stem cell clinical research. and explicitly prohibit the publication of stem cell clinical research advertisements, limit a number of measures to protect the rights and interests of patients. Data show that it is estimated that by 2016, the market size of the domestic stem cell industry will reach 100 billion yuan. Some people in the industry believe that with the announcement of the management measures, the stem cell industry, especially in the field of treatment, will usher in spring. Stem cell research has a clear tendency to pursue profits. Stem cells are a class of stem cells with self-
2015-08-26
Food and Drug Administration Launches 2015 National Safe Drug Use Month
The Food and Drug Administration of all provinces, autonomous regions, and municipalities directly under the Central Government, and the Food and Drug Administration of Xinjiang Production and Construction Corps: According to the requirements of the "National Food and Drug Safety Science Popularization Action Plan (2011-2015)", the "National Safe Drug Month" (Hereinafter referred to as safety month). In order to effectively carry out this year's safety month activities, the relevant matters are hereby notified as follows: the 1. time is arranged from September 1 to October 31, 2015. 2. publicity focuses on publicizing and implementing the "Opinions of the State Council on Reforming the Review and Approval System for Drugs and Medical Devices" (Guo Fa [2015] No. 44
Hot attention: how to improve the current drug bidding procurement system?
The successive introduction of No. 7 and No. 70 has outlined the basic outline of the general direction and rules of regulation and control for the future purchase of drugs in various places. With reference to the above-mentioned basic rules and combined with the actual situation of various regions, it has become a dynamic mode of a new round of online procurement to continuously absorb good local innovation experience and measures for nationwide integration and promotion. Any policy and system has its positive aspects, but also some aspects that may be omitted or need to be further improved. Some thinking suggestions are also put forward from the perspective of industry and enterprises. The fairness, rationality and scientificity of the recruitment catalogue Anhui, Fujian and other places are all based on medical insurance, agricultural cooperation and basic drug products.
About Wuyao
Introduction to Wuyao
Organizational Structure
Enterprise honor
Enterprise culture
Development process
Product display
About Yangxin
Company Introduction
Intermediates/Fine Chemicals
Food Additives
API
News
Company News
Industry News
Media coverage
Network
Business Layout
Domestic customers
Foreign customers
Contact Us
Contact Information
Online message
